Back to Search Start Over

Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever

Authors :
Mustafa Sunbul
Sener Barut
Hurrem Bodur
Ilkay Bozkurt
Resat Ozaras
Irfan Sencan
Rahmet Guner
Mehmet Bakir
Hakan Leblebicioglu
Zülal Özkurt
Nurcan Baykam
Derya Yapar
Seyit Ali Büyüktuna
Ayşe But
Gürdal Yilmaz
Iftihar Koksal
Gönül Çiçek Şentürk
Naci Murat
Ondokuz Mayıs Üniversitesi
Hitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
[Leblebicioglu, Hakan -- Sunbul, Mustafa] Ondokuz Mayis Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Samsun, Turkey -- [Barut, Sener] Gaziosmanpasa Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Tokat, Turkey -- [Buyuktuna, Seyit Ali] Cumhuriyet Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Sivas, Turkey -- [Ozkurt, Zulal] Ataturk Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Erzurum, Turkey -- [Yapar, Derya] Hitit Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Corum, Turkey -- [Yilmaz, Gurdal] Karadeniz Tech Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Samsun, Turkey -- [Guner, Rahmet] Yildirim Beyazit Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Ankara, Turkey -- [But, Ayse] Ankara Numune Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey -- [Senturk, Gonul Cicek] Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey -- [Murat, Naci] Ondokuz Mayis Univ, Dept Ind Engn, Fac Engn, Samsun, Turkey -- [Ozaras, Resat] Istanbul Univ, Dept Infect Dis & Clin Microbiol, Cerrahpasa Med Sch, Istanbul, Turkey
yapar, derya -- 0000-0003-3566-9751
Leblebicioglu, Hakan -- 0000-0002-6033-8543
Publication Year :
2016
Publisher :
Elsevier, 2016.

Abstract

WOS: 000384856200002<br />PubMed ID: 27424492<br />Introduction: The information of discharge criteria in patients with Crimean-Congo Hemorrhagic Fever (CCHF) is limited. In this study, we aimed to determine the clinical and laboratory parameters used in discharging the patients by the experienced centers. Materials and methods: The study was done in 9 reference centers of CCHF from May 1, 2015 to December 1, 2015 and included laboratory-confirmed patients with CCHF. The study was prospective, observational and non-interventional. Results: The study included 260 patients. Mean age was 51.3 +/- 16.3 years; 158 (60.8%) were male. Mean hospital stay was 7 +/- 2.6 days. The decision of discharging was taken considering clinical and laboratory findings. On discharge, no patients had fever or hemorrhage. The patients were followed-up clinically and a repeat CCHF PCR was not studied. All centers considered the following criteria for discharge: no fever and hemorrhage, improvement in clinical findings and laboratory studies. For all patients except one, platelet count was >50,000/mm(3) and had a tendency to increase. Prothrombin time and international normalized ratio (INR) were normal in 258 (99.6%) and 254 (98.1%) patients respectively. Alanine aminotransferase (ALT) was either normal or not higher than 10-fold and had a tendency to decrease in 259 (99.6%) patients. ALT and aspartate aminotransferase (AST) levels were not taken as discharge criteria with priority. During 30 days following the discharge, complication, relapse, or secondary transmission were not reported. Conclusions: The discharging practice of the centers based on clinical and laboratory parameters seems safe considering no complications, relapses, or secondary infection thereafter. Current discharge practice of the centers composed of no fever and hemorrhage, improvement in clinical findings, platelet count of either >100,000/mm(3) or >50,000/mm(3) with a tendency to increase, and normal bleeding tests can be used as the criteria of discharge. (C) 2016 Elsevier B.V. All rights reserved.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....ffc670f79c36625daebf01100d815848
Full Text :
https://doi.org/10.1016/j.antiviral.2016.07.010